CCXI Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Oct 2022 @ 16:00):

Stats
Today's Volume	656 224
Average Volume	2.02M
Market Cap	0.00
EPS	$-0.450 ( Q2 \| 2022-08-08 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-25.93 (Sector) 42.63 (Industry) 24.32
ATR14	$0.378 (0.73%)

AADI -2.65%

ABCL 2.38%

ABCM 0.04%

ABEO -1.90%

ABIO -1.69%

ABOS 0.00%

ABSI 2.21%

ABUS -2.30%

ABVX -2.03%

ACAD -0.45%

ACER -17.95%

ACET -5.08%

ACGN 1.29%

ACHL -2.20%

ACHV -1.29%

ACIU -1.50%

ACLX 0.58%

ACRV -4.79%

ACST -3.58%

ACXP 1.38%

ADAG 4.64%

ADAP -4.25%

ADGI 0.87%

ADIL 0.54%

ADMA -2.45%

ADPT 0.30%

ADTX -3.47%

ADVM -3.40%

ADXN -1.60%

AEON -3.74%

AEZS -2.49%

AFMD -1.05%

AGEN -2.56%

AGIO -2.42%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -1.63%

AKRO -2.43%

AKTX 4.08%

AKUS 0.00%

ALBO 0.00%

ALDX -1.51%

ALEC -0.46%

ALGS -1.16%

ALKS 0.08%

ALLK -8.51%

ALLO -4.79%

ALLR -3.37%

ALNA 3.16%

ALNY 1.95%

ALPN 0.02%

ALPX 0.00%

ALRN 0.33%

ALT -9.58%

ALVR 2.59%

ALXN 0.00%

ALXO -11.19%

ALZN 1.97%

AMRN -0.73%

AMTI -3.13%

ANAB 1.51%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX -0.98%

ANPC -3.15%

APGE -0.75%

APGN 8.48%

APGNW 30.65%

APLM -6.47%

APLS 1.11%

APLT -3.72%

APM -2.94%

APOP 0.38%

APRE 0.60%

APTO 6.30%

APTX 3.17%

APVO 0.18%

ARAV -13.39%

ARCT -4.40%

ARDS -14.23%

ARDX -0.17%

ARGX -1.09%

ARNA 0.00%

ARPO -0.90%

ARQT -1.04%

ARTL -2.50%

ARTLW 0.00%

ARVN 5.80%

ARWR -1.67%

ASLN -5.07%

ASMB -8.31%

ASND -1.27%

ATAI -1.11%

ATHA 5.48%

ATHE 0.56%

ATHX -33.50%

ATNF 0.99%

ATOS 1.46%

ATRA -4.10%

ATXI 1.93%

ATXS -0.33%

AUPH -0.81%

AURA 1.91%

AUTL -1.58%

AVBP -1.06%

AVEO 0.00%

AVIR -0.44%

AVRO -1.41%

AVTE -4.17%

AVTX -1.25%

AVXL -2.84%

AXLA 0.00%

AXSM -1.28%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 2.46%

BCAB 4.58%

BCDA -2.23%

BCDAW -41.77%

BCEL 0.00%

BCLI 5.82%

BCRX 1.48%

BCTX 8.16%

BCTXW -16.32%

BCYC 1.30%

BDRX -4.94%

BDTX -0.64%

BEAM 1.11%

BFRA -2.91%

BGNE -2.86%

BIOR -5.21%

BIVI 3.03%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.89%

BLTE -0.62%

BLU 0.03%

BLUE -0.19%

BMEA -11.14%

BMRN 0.58%

BNOX 4.61%

BNTC -0.42%

BNTX -1.57%

BOLD -8.47%

BOLT 0.72%

BPMC -0.69%

BPTH 1.42%

BPTS -13.47%

BRNS -0.74%

BRTX -2.36%

BTAI 31.15%

BTTX 53.33%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.39%

CABA 1.46%

CADL -1.31%

CALA 0.00%

CALC -1.77%

CALT -1.14%

CAPR -2.80%

CARA 0.18%

CARM 11.79%

CASI -1.65%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -5.22%

CCCC -5.21%

CCXI 0.00%

CDAK 0.00%

CDIO -2.20%

CDIOW 24.00%

CDMO -2.78%

CDMOP 0.04%

CDT -12.24%

CDTTW -39.60%

CDTX -1.92%

CDXC 0.41%

CDXS 7.24%

CELC -3.73%

CELU -0.67%

CELUW 11.80%

CERC -1.68%

CERE -1.01%

CERO -3.40%

CEROW -22.75%

CFRX -27.95%

CGEM -2.13%

CGEN -3.31%

CGON -0.73%

CGTX -4.56%

CHMA -6.00%

CHRS 0.32%

CINC 0.00%

CING 0.26%

CINGW 34.95%

CKPT -2.42%

CLBS -16.75%

CLDX -1.96%

CLGN 0.34%

CLLS -4.15%

CLNN 2.42%

CLNNW 0.00%

CLRB 8.55%

CLSD 0.43%

CLSN -0.68%

CLVS 0.00%

CMMB -0.98%

CMND 2.42%

CMPI 0.00%

CMPX -7.48%

CMRA 0.00%

CMRAW 33.33%

CMRX -3.04%

CNCE 0.00%

CNSP -35.56%

CNST 0.00%

CNTA -0.67%

CNTB 0.00%

CNTX -6.85%

COCP -2.00%

COEPW 32.45%

COGT -2.04%

CORT 2.37%

COYA -1.46%

CPRX -1.06%

CRBP -3.18%

CRBU -4.26%

CRDF -0.44%

CRGX 0.64%

CRIS -1.70%

CRNX -5.82%

CRSP 1.31%

CRTX 2.63%

CRVO -2.50%

CRVS 1.82%

CSBR -1.59%

CTCX -1.60%

CTIC 0.06%

CTMX -3.31%

CTNM -2.33%

CTXR 2.84%

CUE 5.57%

CVAC -2.26%

CVKD 0.10%

CWBR 2.80%

CYAD -12.96%

CYCC 8.18%

CYCCP 5.49%

CYCN 0.43%

CYT -2.27%

CYTK -1.85%

CYTO -2.70%

DARE 6.41%

DAWN 0.67%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 28.69%

DNLI -1.00%

DNTH -9.20%

DOMH -1.58%

DRMA -1.10%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.85%

DRTSW 0.00%

DRUG 0.95%

DSGN -2.11%

DTIL 0.56%

DYAI 10.32%

EARS -1.77%

EDIT -2.52%

EDSA 3.19%

EFTR 4.68%

EFTRW -51.85%

EIGR -9.21%

ELAB -1.00%

ELDN 8.02%

ELEV -5.81%

ELOX 7.69%

ELTX -0.88%

ELVN -4.35%

ELYM 2.30%

ENGN -3.45%

ENGNW 0.00%

ENLV 2.54%

ENOB 1.79%

ENSC 5.16%

ENTA -0.57%

ENTO -2.42%

ENTX 2.08%

ENVB 1.42%

EPIX -0.31%

EPRX -2.97%

EPZM 0.00%

EQ 0.32%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.20%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 87.05%

ETNB -0.51%

ETON 2.13%

ETTX 0.00%

EVAX -2.14%

EVGN 3.97%

EVLO 0.00%

EWTX 0.00%

EXAI -0.95%

EXEL -0.20%

EYEG -0.69%

EYEN 0.95%

EYPT 0.97%

FATE -7.39%

FBIO 0.89%

FBIOP 0.92%

FBLG -15.40%

FBRX -0.04%

FDMT -3.80%

FENC -1.29%

FGEN -4.70%

FHTX 2.67%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -2.23%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 0.13%

FULC -3.34%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -6.28%

GANX -2.31%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -4.09%

GHRS -2.13%

GLMD -5.09%

GLPG -2.26%

GLSI 1.69%

GLTO -0.57%

GLUE -2.51%

GLYC -10.13%

GMAB -0.54%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -3.91%

GNLX 1.33%

GNPX 0.98%

GNTA 3.94%

GOSS -11.71%

GOVX 5.00%

GOVXW -49.04%

GPCR -6.93%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -0.32%

GRTX 2.57%

GTHX 0.91%

GUTS -5.31%

GXGXW 41.67%

GYRE -7.21%

HALO -1.17%

HARP 0.09%

HCWB -3.75%

HEPA -3.64%

HGEN -84.62%

HILS 5.66%

HLVX 0.08%

HOOK 0.00%

HOTH -2.70%

HOWL -1.50%

HRMY 0.83%

HRTX 4.26%

HSTO 0.00%

HUMA 0.60%

HUMAW -0.01%

IBRX -3.51%

ICCC 0.22%

ICPT 0.21%

ICU 18.84%

ICUCW 20.20%

ICVX -0.91%

IDRA -23.04%

IDYA -1.55%

IFRX -1.80%

IGMS -0.44%

IKNA 1.19%

IKT 1.42%

IMAB 2.33%

IMCR -2.99%

IMGN 0.02%

IMGO 0.00%

IMMP 6.08%

IMMX -7.33%

IMNM -1.52%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX -0.42%

IMTX -1.67%

IMTXW 6.00%

IMUX 1.56%

IMV 0.00%

IMVT -3.56%

INAB -0.01%

INBX 0.93%

INCY -0.92%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM 1.92%

INMB 1.95%

INO -2.47%

INSM -1.13%

INTS -2.75%

INVA 0.50%

INZY 1.03%

IOBT -11.02%

IONS 0.19%

IOVA -1.95%

IPA 0.00%

IPHA 5.58%

IPSC -1.95%

IRON -2.68%

ISEE 0.38%

ITOS -1.90%

ITRM 1.67%

IVA 6.96%

IVVD -2.47%

JAGX 1.84%

JANX -3.54%

JAZZ -0.66%

JNCE 0.00%

JSPR -5.96%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.54%

KALV -1.22%

KDNY 0.22%

KMPH -0.34%

KNSA -2.64%

KNTE -0.38%

KOD -6.72%

KPRX 0.96%

KPTI -2.29%

KRBP -10.00%

KRON 1.05%

KROS -1.20%

KRRO -8.20%

KRTX 0.03%

KRYS -1.01%

KTRA 15.68%

KTTA 8.16%

KTTAW 0.92%

KURA -1.12%

KYMR -2.34%

KYTX -3.26%

KZIA 2.65%

KZR -0.21%

LABP 0.57%

LBPH -2.21%

LBPS 0.00%

LBPSW 14.81%

LEGN 2.18%

LENZ -3.30%

LEXX 0.76%

LEXXW -14.63%

LGND -1.33%

LGNDV 0.00%

LGVN -10.08%

LIAN -8.28%

LIFE 2.70%

LIPO -11.13%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 1.65%

LPCN -2.94%

LPTX -1.10%

LQDA -0.57%

LRMR -2.49%

LSTA -4.06%

LTRN 1.37%

LUMO -1.32%

LVTX -1.03%

LXEO -4.21%

LXRX -1.76%

LYEL -33.33%

LYRA 1.32%

MACK 0.10%

MBIO -11.82%

MBRX -2.57%

MCRB 2.61%

MDGL -2.76%

MDNA -13.16%

MDWD 0.03%

MDXG -2.50%

MEIP -0.13%

MESO -2.08%

MGNX -3.03%

MGTA -7.74%

MGTX -3.33%

MGX -4.83%

MIRM -1.84%

MIRO 0.59%

MIST 0.77%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX -1.06%

MLYS -5.88%

MNKD -0.95%

MNMD 0.50%

MNOV 2.11%

MNPR -5.01%

MOLN 1.79%

MOR 1.20%

MORF -2.60%

MREO -3.57%

MRKR 2.68%

MRNA -5.07%

MRNS -4.04%

MRSN -1.67%

MRTX -0.17%

MRUS 0.32%

MRVI -1.97%

MTCR -1.29%

MTEM 4.95%

MTP -18.50%

MURA -0.93%

MYMD 5.41%

NAMS 1.88%

NAMSW 0.43%

NAUT 1.78%

NBRV 0.71%

NBSE -1.56%

NBTX 8.61%

NCNA 1.82%

NERV -0.63%

NEXI 4.04%

NGM -1.28%

NGNE -1.25%

NKGN 9.24%

NKGNW 8.00%

NKTR -4.21%

NKTX -4.24%

NLSP 8.44%

NLSPW 26.67%

NMRA -1.49%

NMTR -42.97%

NOVN -24.84%

NRBO 11.00%

NRIX -0.50%

NRSN -5.12%

NRSNW 0.00%

NRXP -5.20%

NRXPW 18.33%

NRXS 4.82%

NTBL 5.06%

NTEC -12.45%

NTHI 0.00%

NTLA -5.38%

NTRBW -31.07%

NUVL -1.05%

NVAX -2.14%

NVCT 4.51%

NVIV -34.28%

NXTC -2.94%

NYMX -0.05%

OABI 0.26%

OABIW -10.06%

OBIO -4.67%

OBSV 0.00%

OCEA -0.70%

OCGN 3.81%

OCS -1.00%

OCUL -1.30%

OCUP 1.31%

ODT -4.27%

OKYO 1.51%

OLMA -5.88%

OMER -0.51%

OMGA 5.42%

ONCO 4.96%

ONCR -3.08%

ONCS 31.87%

ONCT -3.05%

ONCY 0.00%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT 2.06%

ORGS 0.65%

ORIC -2.97%

ORMP 21.46%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.81%

OVID -1.43%

OYST 0.00%

PALI 2.58%

PASG -1.30%

PBLA -7.50%

PBM -8.21%

PBYI 1.35%

PCSA 0.00%

PCVX -0.01%

PDSB -3.64%

PEPG 1.85%

PGEN -2.99%

PHAR 1.51%

PHAS 0.00%

PHAT -1.16%

PHIO -0.83%

PHIOW 36.47%

PHVS -6.81%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -0.92%

PLUR 5.78%

PMN 0.72%

PMVP 0.00%

PNT 0.16%

PPBT -6.84%

PRAX 1.02%

PRDS 0.93%

PRLD -3.17%

PROG -3.47%

PROK -0.45%

PRQR 0.00%

PRTA -2.07%

PRTC 0.49%

PRTG -0.54%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -8.54%

PSTX -0.39%

PTCT -0.54%

PTE -0.82%

PTGX -1.14%

PTIXW -49.04%

PULM 2.60%

PXMD 0.00%

PYPD 0.07%

PYXS 1.47%

QLGN -8.22%

QNCX 5.70%

QNRX 0.37%

QSI -11.86%

QSIAW -3.13%

QTTB -1.42%

QURE -0.67%

RAIN -1.63%

RANI 6.42%

RAPT -2.89%

RARE 1.53%

RCKT -7.67%

REGN -0.34%

RENB -3.42%

REPL -2.61%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 4.38%

RGLS -5.37%

RGNX -5.19%

RIGL -3.28%

RLAY -3.71%

RLMD 0.33%

RLYB -0.67%

RNA 0.21%

RNAC -5.94%

RNAZ -0.63%

RNXT 0.01%

ROIV -1.75%

ROIVW 4.56%

RPHM -0.31%

RPRX 0.28%

RPTX -2.79%

RUBY 2.70%

RVLP -32.05%

RVMD -0.85%

RVMDW -30.00%

RVNC 2.34%

RVPH -1.19%

RVPHW 1.62%

RXDX 0.09%

RXRX -3.04%

RYTM -5.50%

RYZB 0.02%

RZLT 0.78%

SABS -1.37%

SABSW -11.81%

SAGE 1.74%

SANA -3.23%

SAVA -0.60%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 5.50%

SCPH 2.40%

SCPS 0.00%

SEEL -4.74%

SEER 1.18%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO 0.90%

SGMT -1.69%

SGTX -2.56%

SIOX 22.63%

SLDB -7.07%

SLGL 4.11%

SLN -4.40%

SLNO -4.08%

SLRX 6.07%

SLS -1.74%

SMMT -2.43%

SNDX 1.51%

SNGX -4.91%

SNPX -3.84%

SONN -1.08%

SPPI -0.49%

SPRB 0.91%

SPRC -2.75%

SPRO 0.05%

SRNE -34.00%

SRPT -1.14%

SRRA 0.00%

SRRK -1.73%

SRZN -2.45%

STAB 0.00%

STOK -4.16%

STRO -2.84%

STSA 0.00%

STTK -0.84%

SURF -0.93%

SVRA -5.00%

SWTX 0.52%

SYBX -1.29%

SYRS -1.03%

TALS -0.73%

TARA -6.19%

TARS -0.02%

TBPH 0.48%

TCBP 2.47%

TCDA 0.00%

TCON 2.46%

TCRR 0.00%

TCRT 1.59%

TCRX 1.45%

TECH -0.11%

TENX 1.91%

TERN -7.84%

TFFP -5.33%

TGTX -2.97%

THRX 0.12%

TIL -1.09%

TLC 0.00%

TLSA -2.59%

TNGX -2.59%

TNXP -6.19%

TNYA -4.36%

TPST 2.92%

TRDA -4.64%

TRVI 2.30%

TRVN 2.97%

TSHA -23.12%

TSVT -2.93%

TTNP -7.66%

TVTX 1.13%

TYRA -7.13%

UBX -2.13%

UNCY -4.04%

URGN -1.27%

UTHR -0.26%

VACC 11.36%

VALN -2.89%

VAXX 80.94%

VBIV 0.78%

VBLT -8.77%

VCEL -0.23%

VCNX 10.35%

VCYT -0.70%

VERA -3.35%

VERU -0.55%

VERV -2.68%

VIGL 6.32%

VINC 2.96%

VIR 0.98%

VIRI -1.61%

VIRX 2.40%

VKTX -1.37%

VLON -13.04%

VNDA -2.44%

VOR -2.02%

VRCA 0.14%

VRDN -4.00%

VRNA -1.26%

VRPX 0.38%

VRTX 0.37%

VSTM -0.85%

VTGN -1.05%

VTVT -2.97%

VTYX -1.46%

VXRT -3.01%

VYGR -0.51%

VYNE -4.62%

VYNT 7.78%

WINT -3.24%

WVE -4.40%

XBIO 0.93%

XBIT 1.04%

XCUR 3.58%

XENE -2.68%

XERS 2.14%

XFOR 2.52%

XLO 4.54%

XLRN 0.00%

XNCR 0.67%

XOMA -2.94%

XOMAO 0.36%

XOMAP -0.82%

XRTX -8.00%

YMAB -1.63%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.89%

ZNTL -0.72%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2022-10-20	Jain Rita	Sell	11 600	Restricted Stock Unit
2022-10-20	Herron Jennifer Lyn	Sell	17 237	Common Stock
2022-10-20	Edwards Thomas A.	Sell	15 723	Restricted Stock Unit
2022-10-20	Parker Geoffrey M.	Sell	15 723	Restricted Stock Unit
2022-10-20	Kanaya Susan M	Sell	90 968	Restricted Stock Unit

INSIDER POWER
-78.69
Last 97 transactions
Buy: 1 451 999 \| Sell: 1 420 462

Volume Correlation

Long: 0.21 (neutral)

Short: 0.67 (moderate)

Signal:(79.007) Neutral

ChemoCentryx, Inc. Correlation

10 Most Positive Correlations
SANB	0.835

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

ChemoCentryx, Inc. Correlation - Currency/Commodity

0.58
( weak )

0.22
( neutral )

0.71
( moderate )

0.47
( neutral )

0.01
( neutral )

-0.87
( strong negative )

ChemoCentryx, Inc. Financials

Annual	2021
Revenue:	$32.22M
Gross Profit:	$31.92M (99.06 %)
EPS:	$-1.890

FY	2021
Revenue:	$32.22M
Gross Profit:	$31.92M (99.06 %)
EPS:	$-1.890

FY	2020
Revenue:	$64.89M
Gross Profit:	$64.89M (100.00 %)
EPS:	$-0.840

FY	2019
Revenue:	$35.95M
Gross Profit:	$0.00 (0.00 %)
EPS:	$-0.980

Financial Reports:

No articles found.

ChemoCentryx, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

ChemoCentryx, Inc.

ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis. The company also develops TAVNEOS for the treatment of patients with severe hidradenitis suppurativa, as well as patients with complement 3 glomerulopathy, and lupus nephritis. In addition, it develops CCX559, an orally administered inhibitor for programmed death protein 1/programmed death-ligand 1 for the treatment of various cancers; and CCX507, an orally administered inhibitor of the chemokine receptor known as CCR9, which has completed Phase I clinical trial for the treatment of inflammatory bowel disease. Further, the company has early-stage drug candidates that targets Th17 driven diseases and CCR6. ChemoCentryx, Inc. was incorporated in 1996 and is headquartered in San Carlos, California. As of October 20, 2022, ChemoCentryx, Inc. operates as a subsidiary of Amgen Inc.